Kyrgyzstan Pharmaceuticals & Healthcare Q3 2018
Kyrgyzstan's small and highly ruralised population will continue to restrict opportunities for multinational pharmaceuticalfirms. While there is considerable potential for growth, the lack of regulatory oversight will create a challenging environment,creating a major access barrier to drugmakers. Moreover, affordability levels are low, resulting in drug demand almost exclusivelywithin the non-branded generic and over-the-counter medicines sectors.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook